Assay developers in biopharma and research labs strive to save time, reduce costs, and ensure accurate and reproducible results. In quantitative PCR (qPCR) assays, multiplexing—the simultaneous ...

Ultra-rapid digital droplet PCR can measure the levels of tumor cells in a tissue sample during surgery in about 15 minutes.

Hologic HOLX has been gaining from new strategic product launches across Diagnostics and Breast Health. However, ...

tuberculosis. This test, the so-called Molecular Bacterial Load Assay (MBLA), represents a novel innovative tool for monitoring TB treatment. The assay measures M. tuberculosis 16S rRNA ...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Rarity Bioscience ...

Hologic's Surgical business has been driving strong broad-based performance by expanding access to technologies in new global ...

The Molecular Diagnostic and Assay Development Hub is focused on expanding our targeted and agnostic diagnostic capabilities against viral threats with pandemic potential. During the two-year start-up ...

Dr. James Dunn will join us to discuss the process for the practical implementation of multiplex molecular assays for infectious diseases at different points of service. Throughout the session, Dr.

Bio-Rad’s assays use real-time polymerase chain reaction technology to amplify and detect specific DNA sequences of target ...

Molecular Devices' CellXpress AI streamlines cell culture processes, reducing human error and improving efficiency in drug ...

“Our study shows that ultra-rapid droplet digital PCR could be a fast and efficient tool for making a molecular diagnosis during surgery for brain cancer,” co-senior author Gilad D ...